Atlas FDA

Simplexa Flu AlB & RSV Direct Assay Kits, intended for use as an aid in the differential diagnosis of influenza A, influ

FDA device recall Z-1144-2014 · posted 2014-03-05 · Terminated

Recall details

Recalling firm
Focus Diagnostics Inc
Reason for recall
Focus Diagnostics initiated the recall of the certain Simplexa Flu AlB & RSV Direct assay kits due to the potential of false positive Flu A, Flu B and RSV signals.
Action taken
Focus Diagnostic initiated this recall on February 4, 2014 by sending recall notification letters to customers via email. The letter dated February 4, 2014, titled "URGENT: SAFETY NOTICE REMOVAL", informed customers of the recall (removal). The letter provided the following information: product description with code, reason for recall, the issue, the risk to health, recommendation, background, actions by customers, contact information, labeling, and response sheet.
Root cause
Under Investigation by firm
Status
Terminated
Product code
OOC
Quantity affected
2,175 kits
Distribution
Worldwide Distribution: US (nationwide) and to countries of:Canada, Sweden, Belgium, Spain, Portugal, Slovenia, and Israel.
Date initiated
2014-02-04
Date posted
2014-03-05
Date terminated
2014-11-01
Location
Cypress, CA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.